The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

(CNN) — The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

The Business Research Company's Farber's Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% on all global market reports with code ONLINE30 - stay informed ...

"Organon discontinues endometriosis drug after Phase II flunk" was originally created and published by Clinical Trials Arena, ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...